Timothy Alexander

Ocugen Raises $130 Million as Gene Therapy Trials Advance MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) extended its expected cash runway into 2028 with a $130 million convertible debt financing as the b […]

E-Impact Clients Land Five Spots on Inc. 5000 LANCASTER, PA — Five clients of Lancaster-based E-Impact Marketing earned places on the 2026 Inc. 5000, giving the digital marketing agency a cluster o […]

Upper Dauphin Vinyl Products Makes Inc. 5000 Debut ELIZABETHVILLE, PA — Upper Dauphin Vinyl Products ranked No. 3,572 on the 2026 Inc. 5000, giving the family-owned Central Pennsylvania outdoor-living c […]

Zook Cabins Makes Inc. 5000 for Fifth Time GAP, PA — Zook Cabins ranked No. 2,991 on the 2026 Inc. 5000, marking the Pennsylvania modular-home builder’s fifth appearance on the national list as […]

Philadelphia Fight Night Puts Jibril Noble in Title Spotlight PHILADELPHIA, PA — An undefeated Philadelphia lightweight will fight for his first championship belt this month as Jibril Noble headlines Teflon P […]

A. Duie Pyle Extends 37-Year Logistics Award Streak WEST CHESTER, PA — A. Duie Pyle ranked first among Northeast and Mid-Atlantic regional less-than-truckload carriers in Logistics Management’s 2026 Que […]

Extreme Pole Buildings Makes Inc. 5000 as Demand Fuels Growth LEOLA, PA — Extreme Pole Buildings has made the Inc. 5000 for the first time, ranking No. 3,290 on the 2026 list as the Lancaster County post-frame b […]

River Station Adds 67 Apartments as Downingtown Expansion Advances DOWNINGTOWN, PA — Hankin Group has opened a 67-unit apartment building at River Station in Downingtown, advancing a second phase that will add 160 r […]

Artesian Maintains Dividend With 135th Straight Payout NEWARK, DE — Artesian Resources Corporation (Nasdaq: ARTNA) will pay a quarterly dividend of $0.3199 per share on Aug. 28, extending the Delmarva w […]

Apache Elevates Fluss, Pony Mail to Top-Level Projects WILMINGTON, DE — The Apache Software Foundation has elevated Apache Fluss and Apache Pony Mail to Top-Level Project status, giving the two o […]

PrimoHoagies Cuts Primo Size Hoagies to $10 for One Day PHILADELPHIA, PA — PrimoHoagies will cut the price of its Primo Size Hoagies to $10 on Thursday, Aug. 13, offering members of its loyalty program a o […]

West Chester Parade Faces Aug. 16 Entry Deadline WEST CHESTER, PA — Businesses, nonprofits, marching bands and other groups seeking a place in the 2026 West Chester Christmas Parade have until S […]

Harmony Sets Investor Appearance as CNS Strategy Advances PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) will participate in the Piper Sandler Virtual CNS Symposium on Thursday, Aug. 1 […]

Medecision Gains Frost & Sullivan Innovation Ranking KING OF PRUSSIA, PA — Medecision was ranked among the leading innovators in U.S. population health management by Frost & Sullivan, strengthening the h […]

Gwynedd Mercy Expands Programs as Workforce Needs Shift GWYNEDD VALLEY, PA — Gwynedd Mercy University is undertaking one of its largest recent academic expansions, adding programs in artificial i […]

Proscia Expands FDA-Cleared Digital Pathology Platform PHILADELPHIA, PA — Proscia received a new U.S. Food and Drug Administration 510(k) clearance for its Concentriq AP-Dx digital pathology platform, e […]

Exyn Wins Federal LiDAR Selection After Technical Review PHILADELPHIA, PA — Exyn Technologies (NASDAQ: EXYN, EXYNW) has secured another U.S. government deployment for its handheld LiDAR technology after an u […]

Acorn Revenue Falls 29% as Hardware Sales Drop WILMINGTON, DE — Acorn Energy Inc. (NASDAQ: ACFN) reported a 29.4% decline in second-quarter revenue as hardware sales to a major telecommunications c […]

Aclaris Raises Capital as Drug Pipeline Spending Accelerates WAYNE, PA — Aclaris Therapeutics Inc. (NASDAQ: ACRS) raised $40.2 million through an at-the-market stock sale after the second quarter, extending its e […]

Context Therapeutics Narrows Pipeline as Quarterly Loss Widens PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) is discontinuing development of one cancer drug candidate and concentrating capital on t […]